Show All Hide All

Marc N. Casper , President and Chief Executive Officer, Thermo Fisher Scientific

Marc Casper has been President and Chief Executive Officer of Thermo Fisher Scientific since October 2009. He joined the company in 2001 as President of the Life Sciences sector of Thermo Electron. He was named Senior Vice President in 2003, and in 2005 was given responsibility for all of the company’s operating divisions. After the merger creating Thermo Fisher Scientific in 2006, Marc was named President, Analytical Technologies, and in 2008 was named Chief Operating Officer.

Prior to joining Thermo Fisher, Marc served as President, Chief Executive Officer and a director of Kendro Laboratory Products. Before Kendro, he worked for clinical diagnostics provider Dade Behring Inc., where he served as President – Americas. Marc began his career at Bain & Company as a strategy consultant and later joined Bain Capital.

Marc earned an MBA with high distinction from Harvard Business School and is a graduate of Wesleyan University, where he received a bachelor’s degree in economics. He serves on the boards of trustees of Brigham & Women’s Hospital and Wesleyan University. He is also vice chair of the U.S.-China Business Council and serves on the board of U.S. Bancorp. He was previously a director of the Advisory Board Company and Zimmer Holdings.

Lisa Britt , Senior Vice President, Chief Human Resources Officer

Lisa joined the company in March 2017 as Senior Vice President and Chief Human Resources Officer, responsible for leading our global Human Resources strategy and operations.

She joined Thermo Fisher after six years with Nexeo Solutions, a Texas-based global leader in the distribution of plastics and chemicals, where she served as Executive Vice President and Chief Human Resources Officer. Prior to Nexeo, Lisa worked for Covidien, a $10 billion global leader in healthcare products. During her 13-year tenure, she served in a number of HR senior leadership roles, most recently as Vice President, Global Human Resources.

Lisa received her bachelor of arts degree from Lander University in Greenwood, South Carolina.

Patrick M. Durbin , Senior Vice President and President, Specialty Diagnostics

Patrick joined the company in 2006 as General Manager, North America, for the Clinical Services business and assumed global leadership of that business in 2008. In 2010, he became President of BioPharma Services, and in October 2015, Patrick was named Senior Vice President and President, Specialty Diagnostics.

Prior to joining Thermo Fisher, Patrick worked for 16 years at Covance, where he held a number of general management, operational, sales and corporate roles. Patrick served on the corporate team that launched Covance as a public company when it spun off from Corning, Inc.

Patrick received his MBA and a bachelor’s degree in biology from St. Joseph’s University in Philadelphia, Pennsylvania.

Gregory J. Herrema , Senior Vice President and President, Customer Channels

Greg joined the company in January 2002 as President, Environmental Instruments. He was named President, Scientific Instruments, in May 2006 and became Senior Vice President and President, Analytical Instruments, two years later. In 2012, Greg was named President, Biosciences, and in January 2014, he became Senior Vice President and President of the company’s Customer Channels business.

Prior to joining Thermo Fisher, Greg spent 14 years at General Electric, including two years at Borg Warner Chemicals (acquired by GE Plastics). While at GE, his career progressed through multiple sales, marketing and general management roles within the Plastics and Transportation Systems divisions.

Greg holds an MBA from Harvard Business School and bachelor’s degrees in chemical engineering from Virginia Tech and the University of Exeter. Greg is past Chairman and current member of the Board of Advisors of ALDA (Analytical, Life Science & Diagnostics Association).

Seth H. Hoogasian , Senior Vice President and General Counsel

Seth joined the company in 1990 as Senior Counsel and became General Counsel in 1992. Prior to joining Thermo Fisher, Seth served as a partner in the Baltimore, Maryland-based law firm of Weinberg and Green, and as an associate at Shaw, Pittman, Potts & Trowbridge in Washington, D.C. Seth is a graduate of Duke University School of Law with a juris doctorate with distinction, and received his Bachelor of Science degree with distinction in mechanical engineering from Cornell University.

Syed Jafry , Senior Vice President and President, Regions

Syed Jafry joined the company in March 2005 as General Manager and Vice President of the Air Quality Instruments business. He was promoted to President of Thermo Fisher China in 2008, and one year later became President, Environmental Instruments. In 2009, Syed was named Senior Vice President of Customer and Commercial Excellence. In 2010, he became President of Thermo Fisher’s Asian operations and Senior Vice President for Customer Excellence. In 2011, he was promoted to Senior Vice President and President, Asia-Pacific and Emerging Markets. In September 2017, his role expanded to include responsibility for Europe, the Middle East and Africa and he was named Senior Vice President and President, Regions.

Syed started his career at Glaxo Pharmaceuticals in London, U.K. He served for 18 years at General Electric, where he held commercial, product management and general management roles in the U.S., the Netherlands, Switzerland and China.

He holds a master’s degree in mechanical engineering from the University of Massachusetts, a master’s certificate in marketing and management from Harvard University Extension School and a Bachelor of Science degree in mechanical engineering from Lahore University in Pakistan.

Michel Lagarde , Senior Vice President and President, Pharma Services

Michel joined Thermo Fisher in August 2017 through the acquisition of Patheon, where he had served as President and Chief Operating Officer.

Prior to joining Patheon in 2016, Michel was Managing Director at JLL Partners, a leading middle-market private equity firm focused on healthcare. At JLL, Michel worked with several of the organization’s portfolio companies, including Patheon, where he helped the executive committee transform the company into a global provider of biopharma development and commercial manufacturing services.

Prior to joining JLL, Michel was Chief Executive Officer and Chief Financial Officer (CFO) of the Domestic Appliances and Personal Care division of Philips Electronics North America. He also previously served as CFO of Philips Electronics in Indonesia and Financial Controller of Philips Electronics Hong Kong, where he was responsible for a $1 billion industrial footprint.

Michel earned a bachelor’s degree in business administration from European University in Antwerp and an executive master’s degree in finance and control from the University of Maastricht and University of Amsterdam.

Frederick M. Lowery , Senior Vice President and President, Life Sciences Solutions and Laboratory Products

Fred joined the company in 2005 as head of operations for the Molecular BioProducts business of Fisher Scientific International. When Fisher Scientific merged with Thermo Electron in 2006, Fred was named Vice President and General Manager of the Chromatography Consumables and Specialty Glass business. In 2010, he became Vice President and General Manager of the Life Science Research business, and in 2011 was named President, Laboratory Consumables. In 2014, Fred was named Senior Vice President and President, Laboratory Products, and in 2016 he also became Senior Operating Officer, Life Sciences Solutions. In 2017, he became President, Life Sciences Solutions and Laboratory Products, leading the BioProduction, Laboratory Products and Laboratory Chemicals businesses, as well as several functions within Life Sciences Solutions.

Earlier in his career, Fred worked for Maytag Corporation and General Motors.

Fred holds a master’s degree in manufacturing management from Kettering University (formerly General Motors Institute of Engineering and Management) and a bachelor’s degree in mechanical engineering from Tennessee Technological University.

Dan Shine , Senior Vice President and President, Analytical Instruments

Dan joined the company in 1998 as a controller, and over the next four years held a number of leadership positions within finance and operations. In 2002, he was appointed business leader for the company’s Elemental Analysis product line and a year later became Vice President and General Manager of that business. In 2007, he was promoted to President, Process Instruments, and in 2011 became President, Chemical Analysis. Dan was named President, Chromatography and Mass Spectrometry, in 2012, and in 2016, became Senior Vice President and President, Analytical Instruments. In September 2017, he also assumed responsibility for Unity Lab Services.

Prior to joining Thermo Fisher, Dan worked for international accounting firm Arthur Andersen for eight years. He holds a bachelor’s degree in economics from Wesleyan University and a master’s degree in professional accounting from the University of Hartford.

Mark P. Stevenson , Executive Vice President and Chief Operating Officer

Mark joined the company as Executive Vice President and President, Life Sciences Solutions, in 2014 through the acquisition of Life Technologies. In August 2017, he was promoted to Chief Operating Officer, with responsibility for all of Thermo Fisher’s life sciences-related businesses as well as our R&D and digital strategies. Mark previously served as President and Chief Operating Officer of Life Technologies, and President and Chief Operating Officer of Applied Biosystems prior to its merger with Invitrogen Corporation in 2008.

At Applied Biosystems, Mark held roles of increasing responsibility in Europe and Japan. He moved to the U.S. in 2004 to establish the Applied Markets Division and, in 2006, was named President of the Molecular and Cellular Biology Division. He has more than 20 years of experience in sales, marketing and international executive management.

Mark received his MBA from Henley Management School in the U.K. and his bachelor’s degree in chemistry from the University of Reading, also in the U.K. He serves as an executive committee board member of the life science association, BIOCOM.

Richard Spoor , Senior Vice President, Global Business Services

Richard Spoor joined Thermo Fisher in April 2017 as Senior Vice President of Global Business Services.

Prior to joining our company, Richard served since June 2014 as Global Head of Product Supply for Bayer Consumer Health, after leading global procurement for Bayer Healthcare for three years. From 2005 to 2011, he was with Merck & Co., serving most recently as Senior Vice President of Global Procurement. Earlier in his career, Richard held various business, procurement and operational leadership positions at leading companies, including Nokia, QP Group and GE Lighting, with responsibilities in the Americas, Asia-Pacific region and Europe.

Richard received a bachelor’s degree with honors in industrial management from Nottingham Trent University in Nottingham, England. He is a fellow of the Chartered Institute of Purchasing and Supply.

Andrew J. Thomson , Senior Vice President and President, EMEA

Andy joined Thermo Fisher Scientific in 2009 as Vice President and General Manager, North America, for the Microbiology business. He was promoted to President, Clinical Diagnostics, in October 2009, and was named Senior Vice President and President, Specialty Diagnostics, in February 2012. In October 2015, Andy became Senior Vice President and President of Europe, the Middle East and Africa.

Prior to joining Thermo Fisher, Andy worked for 20 years in the diagnostics industry, including nine years with Dade Behring (now Siemens Diagnostics), where he served in various marketing roles, and ultimately became Vice President of Marketing for the company’s North America region. Andy then joined Roche Diagnostics, where, during his six-year tenure, he was Senior Vice President of Global Marketing for Centralized Diagnostics in Germany and later led all commercial activities for the Professional Diagnostics group in the U.S.

Andy holds an honors degree in economics from Queen’s University in Kingston, Canada.

Stephen Williamson , Senior Vice President and Chief Financial Officer

In August 2015, Stephen was named Senior Vice President and Chief Financial Officer, responsible for the company’s tax, treasury, financial reporting and investor relations functions. He joined the company in 2001 as Vice President, European Financial Operations, based in the U.K., and oversaw the company’s integration activities across Europe. In 2004, Stephen moved to the U.S. and held finance leadership roles for a number of the company’s operating businesses. In 2008, he became Vice President of Financial Operations for Thermo Fisher Scientific and led the finance support function for all of the company’s businesses.

Stephen joined Thermo Fisher from Honeywell International (formerly AlliedSignal), where he served as Vice President and Chief Financial Officer, Asia-Pacific, in Singapore and held other finance roles in corporate development and operational finance. He began his career with Price Waterhouse in the transaction support group and the audit practice, working in both London and New York.

Stephen holds a bachelor's degree in accounting and finance from the University of Wales and is a member of the Institute of Chartered Accountants of England and Wales.

Thermo Fisher Scientific At a Glance

More than $20 billion in annual revenue and

65,000 Employees

Premier Brands

– Thermo Scientific

– Applied Biosystems

– Invitrogen

– Fisher Scientific

– Unity Lab Services

Read more

NYSE: TMO (Common Stock)Dec 12, 2017 12:16 PM

Exchange NYSE (US Dollar)NYSE

Price 189.69

Change +0.20  (+0.11%)

Volume 601,844

% Change

Intraday High 189.88

52 Week High 201.20

Intraday Low 187.62

52 Week Low 139.88

Today's Open 189.41

Previous Close 189.49

Minimum 20 minute delay

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit http://www.thermofisher.com.

The world leader in serving science